Medication delivered by a novel gel cured 100% of mice with an aggressive brain cancer, a striking result that offers new hope for patients diagnosed with glioblastoma, one of the deadliest and most common brain tumors in humans.
Combining an anticancer drug with an antibody, researchers developed a novel gel that cured glioblastoma brain cancer in 100% of mouse models. The findings offer new hope in the fight against the most deadly form of brain cancer in humans. The gel triggers an immune response and, when the cancer was reintroduced, the immune system alone helped beat the cancer without additional medications.